High Rate of Treatment Completion in Program Settings with 12-Dose Weekly Isoniazid and Rifapentine (3HP) for Latent Mycobacterium tuberculosis Infection

BACKGROUND: RCTs demonstrated the newest LTBI regimen, 12 weekly doses of directly observed isoniazid and rifapentine (3HP), as efficacious as 9 months of isoniazid (9H) with a greater completion rate (82% versus 69%); however, 3HP has not been assessed in routine health care settings. METHODS: Obse...

詳細記述

保存先:
書誌詳細
出版年:Clin Infect Dis
主要な著者: Sandul, Amy L., Nwana, Nwabunie, Holcombe, J. Mike, Lobato, Mark N., Marks, Suzanne, Webb, Risa, Wang, Shu-Hua, Stewart, Brock, Griffin, Phil, Hunt, Garrett, Shah, Neha, Marco, Asween, Patil, Naveen, Mukasa, Leonard, Moro, Ruth N., Jereb, John, Mase, Sundari, Chorba, Terence, Bamrah-Morris, Sapna, Ho, Christine S.
フォーマット: Artigo
言語:Inglês
出版事項: 2017
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5709238/
https://ncbi.nlm.nih.gov/pubmed/28575208
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cix505
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料